TCR2 Therapeutics Competitors and Similar CompaniesClear all

TCR2 Therapeutics's competitors and similar companies include PolyPid, MetaboGen AB and Metabolon.

	TCR2 Therapeutics TCR2 Therapeutics is a discovery-stage pharmaceutical company focused on engineering T cells for cancer therapy.	PolyPid PolyPid is a company developing a technology platform that enables a controlled and prolonged release of active pharmaceutical ingredients (API).	MetaboGen AB As a pioneering company, MetaboGen is addressing the microbiome to understand health and disease.	Metabolon Global leader in metabolomics for precision medicine, biomarker discovery, and advancing pharma & life sciences research.
Founding Date	Founding Date 2015	Founding Date 2008	Founding Date 2011	Founding Date 2000
Type	Type Subsidiary	Type Public	Type Private	Type Private
Tags	Tags Healthcare Technology biotech healthtech pharma platform	Tags Healthcare Technology biotech healthtech pharma	Tags Healthcare Technology biotech healthtech medical diagnostics pharma platform	Tags Healthcare Technology biotech healthtech pharma
Locations	Locations Cambridge, US HQ	Locations Petah Tikva, IL HQ Summit, US	Locations Mölndal, SE HQ Stockholm, SE	Locations Morrisville, US HQ Hallbergmoos, DE München, DE
Employees	Employees 445% increase	Employees 57	Employees 1	Employees 1911% increase
Financial
Net income	Net income ($151.8m) (FY, 2022)	Net income ($34.2m) (FY, 2025)	Net income N/A	Net income N/A
Funding
Total funding raised	Total funding raised $ 173.3m	Total funding raised $ 103.8m	Total funding raised N/A	Total funding raised $ 95.4m